Artículos Científicos en Ingles

Artículos Científicos RSS JASN

Depletion of Gut Microbiota Protects against Renal Ischemia-Reperfusion Injury

An accumulating body of evidence shows that gut...

Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1{beta} and IL-18 and Arrests CKD

The innate immune system has been implicated in both AKI...

Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI

Overexpression of the proximal tubular enzyme myo...

Investigations of Glucocorticoid Action in GN

For several decades, glucocorticoids have been used...

Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy

Lowe syndrome and Dent disease are two conditions that...

The Urine Preservative Acetic Acid Degrades Urine Protein: Implications for Urine Biorepositories and the AASK Cohort Study

Patients enrolled in the African American Study of...

Modeling Monogenic Human Nephrotic Syndrome in the Drosophila Garland Cell Nephrocyte

Steroid-resistant nephrotic syndrome is characterized by...

High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney

Excessive fat intake contributes to the progression of...

Genetic Variants Associated with Circulating Parathyroid Hormone

Parathyroid hormone (PTH) is a primary calcium...

HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy

Idiopathic membranous nephropathy (MN) is associated...

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

Fabry disease leads to renal, cardiac, and...

Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis

Patients with CKD on hemodialysis exhibit increased...

MAGI2 Mutations Cause Congenital Nephrotic Syndrome

Steroid–resistant nephrotic syndrome (SRNS), a...

Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN

In C3 glomerulopathy (C3G), the alternative pathway of...

Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial

The vasopressin–cAMP–osmolality axis is abnormal in...

Páginas